BIO Soars 37% After Upbit Listing Sparks Massive Buying Frenzy

BIO jumped 40% after Upbit listing, with trading volume soaring 350%.

Korean traders drive strong demand, pushing BIO into the top 200 cryptocurrencies.

RSI shows overbought levels, hinting at a possible short-term correction ahead.

The crypto market showed a modest rise, but Bio Protocol stole the spotlight. The token surged nearly 40% on October 20, reaching a daily high of $0.11 before cooling slightly. Trading volume skyrocketed by more than 350%, hitting $136 million. The sharp rally followed news that Upbit, South Korea’s largest exchange, officially listed BIO across several trading pairs. The listing has fueled a wave of optimism among investors and the Korean crypto community.

Upbit Listing Triggers Heavy Trading Activity

BIO’s trading debut on Upbit began on October 20 at 6:00 p.m. KST. A brief five-minute pre-open phase preceded the launch to manage liquidity and prepare traders. Upbit implemented temporary rules to ensure market stability, including a ±10% price band during the first five minutes. Additionally, the exchange restricted market and trailing stop orders for two hours, allowing only limit orders during the initial period. These measures aimed to control volatility as excitement spread across Korean crypto circles.

The listing pushed BIO’s market capitalization up by nearly 40%, propelling the project into the top 200 cryptocurrencies by valuation. Investors reacted swiftly, accumulating positions as trading pairs in KRW, BTC, and USDT became available. The increased exposure through Upbit adds to BIO’s growing list of high-profile exchange listings. Earlier this year, the token secured spots on Coinbase and Bithumb. Binance had also listed BIO last year, signaling expanding institutional and retail interest in the project.

Why Bio Protocol Stand Out

Bio Protocol operates at the intersection of blockchain and biotechnology. The platform supports decentralized funding for biotech research by tokenizing intellectual property and enabling community governance through DAOs. This structure allows researchers and investors to collaborate transparently on innovative science projects.

The launch of the Bio Launchpad earlier this year boosted engagement. More than 8,000 participants joined the first wave of projects, according to co-founder Clepp. This growth highlights the platform’s increasing adoption within the decentralized science movement. From a technical standpoint, the recent surge has pushed BIO into overbought territory.

The four-hour chart shows the RSI hovering near extreme levels, suggesting possible short-term profit-taking. If prices drop below $0.10, traders might see a brief pullback before consolidation. However, the MACD remains firmly bullish. The widening histograms and positive crossover indicate strong upward momentum. Resistance lies near $0.125, and a confirmed breakout could propel the token toward $0.15.

Despite this strong performance, BIO still trades about 88% below its all-time high of $0.9226 recorded in January. BIO’s strong rally underscores renewed confidence following the Upbit listing. The combination of growing exchange exposure, community participation, and expanding use cases adds long-term appeal.